Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 7 Colorectal Neoplasms 6 Biliary Tract Neoplasms 5 Sarcoma 3 Rectal Neoplasms 3 Colonic Neoplasms 3 Advanced or Metastatic Solid Tumors 3 Solid Tumors 2 Nasopharyngeal Carcinoma 2 Gastrointestinal Stromal Tumors 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Thymoma 1 Stomach Neoplasms 1 Squamous Non-small Cell Lung Cancer 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Rare Tumour 1 Prostatic Neoplasms 1 Piebaldism 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neoplasms, Multiple Primary 1 Neoplasm Metastasis 1 NSCLC 1 Meningeal Carcinomatosis 1 Lung Neoplasms 1 Histiocytoma, Malignant Fibrous 1 HER2-positive Breast Cancer 1 Gastrointestinal Neoplasms 1

Interventions

Cyclophosphamide 7 pembrolizumab 6 Radiotherapy 6 Cisplatin 6 Sunitinib 5 Carboplatin 5 Paclitaxel 4 Thymectomy 3 130-nm albumin-bound paclitaxel 3 selinexor 2 lenvatinib 2 fludarabine 2 Taxes 2 Robotic Surgical Procedures 2 Ramucirumab 2 Prednisone 2 Pemetrexed 2 Octreotide 2 Nivolumab 2 N,1,4,4-tetramethyl-8-((4-(4-methylpiperazin-1-yl)phenyl)amino)-4,5-dihydro-1H-pyrazolo(4,3-h)quinazoline-3-carboxamide 2 Methylprednisolone 2 Imatinib Mesylate 2 Etoposide 2 Erlotinib Hydrochloride 2 Doxorubicin 2 Chemoradiotherapy 2 Celecoxib 2 zimberelimab 1 vorolanib 1 saracatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Thymoma × envafolimab × Clear all

NCT06019468 2026-05-08

Neoadjuvant Treatment For Locally Advanced Thymic Cancer

Shanghai Pulmonary Hospital, Shanghai, China

Phase 2 Recruiting

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡